MedTrace Logo

Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease

NCT05044338 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2021-09-16

No results posted yet for this study

Summary

The key technology research and standard evaluation system of elderly heart valve disease evaluation is to further establish a domestic multi center and large sample full information big data platform of elderly heart valve disease based on the previous Chinese elderly valve disease cohort and clinical research platform and the national valve disease surgery data platform.

Conditions

  • Valvular Heart Disease

Interventions

DIAGNOSTIC_TEST

imaging

(1) Build the first full information big data cloud platform for diagnosis, treatment and clinical research of senile valvular disease in China (2) To establish a cohort of elderly patients with valvular disease in China and a complete database covering clinical information, functional, imaging evaluation, treatment and follow-up; (3) To analyze the clinical characteristics, functional status and imaging characteristics of senile valvular disease in China, and to understand the current situation of diagnosis and treatment; To establish a whole process standardized comprehensive evaluation system of clinical indicators of senile valvular disease combined with a variety of imaging for Chinese people.

Sponsors & Collaborators

  • Yongjian Wu

    lead OTHER_GOV

Principal Investigators

  • yongjian wu, doctor · Fuwai Hospital, National Center for Cardiovascular Diseases，Chinese Academy of Medical Sciences

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05044338 on ClinicalTrials.gov